Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Control Trial for the Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction

NCT05880160 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT05880160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05880160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Control Trial for the Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Completed
Start date
July 14, 2023
Completion date
June 24, 2026
Enrollment
90 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, therapy-related, cardiotoxicity, heart failure, her2-positive breast cancer